Regeneron antibody therapy cuts hospitalization rates
People with mild-to-moderate COVID-19 who were treated with a monoclonal antibody "cocktail" had lower hospitalization… Read More
4 years ago
Regeneron
COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies
Regeneron Pharmaceuticals' COVID-19 antibody cocktail reduces deaths in hospitalised patients who have not mounted their… Read More
4 years ago